Hillsdale Investment Management’s DexCom DXCM Stock Holding History

Hillsdale Investment Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,300	Closed	-$883K	–	690
2025 Q4	$883K	Buy	+13,300	New	+$860K	0.02%	401
2023 Q3	–	Sell	-2,800	Closed	-$360K	–	589
2023 Q2	$360K	Sell	2,800 -650	-19%	-$78.6K	0.03%	308
2023 Q1	$401K	Buy	+3,450	New	+$386K	0.03%	377
2015 Q2	–	Sell	-22,800	Closed	-$355K	–	520
2015 Q1	$355K	Buy	+22,800	New	+$344K	0.09%	216

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Hillsdale Investment Management's DXCM Position: Q1 2026 in Review

Hillsdale Investment Management sold out of DexCom (DXCM) in Q1 2026, closing a stake of 13,300 shares — an estimated $883K sold.

Hillsdale Investment Management first reported a position in DXCM in Q1 2015 and held it in 4 quarters. The position peaked at $883K in Q4 2025. 959 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

Hillsdale Investment Management reported no remaining DexCom position as of Q1 2026 after selling out during the quarter.
Hillsdale Investment Management sold 13,300 DexCom shares in Q1 2026, an estimated $883K.
Hillsdale Investment Management first reported a position in DexCom in Q1 2015 and held it in 4 quarters.
Hillsdale Investment Management's DexCom position peaked at $883K in Q4 2025.
959 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.